Shulou(Shulou.com)11/24 Report--

Thanks to CTOnews.com netizen Xiao Zhan for the clue delivery! CTOnews.com, May 2 (Xinhua)-- A patent dispute between Apple and medical technology company Masimo has ended, but ended in a mistrial. The court jury failed to reach a unanimous verdict after hearing the Masimo case alleging that Apple stole trade secrets and infringed patents.

Masimo is a company specializing in the production of pulse oximeter and other medical equipment, its technology is widely used in hospitals and clinics. In 2013, Apple approached Masimo and expressed its intention to establish a "partnership" with it. During the meeting, Masimo revealed details of its pulse oximeter technology. Apple then began poaching Masimo employees, including Dr. Michael O'Reilly, Masimo's chief medical officer. In 2020, Masimo filed a formal lawsuit accusing Apple of stealing trade secrets from Apple Watch's blood oxygen sensor and infringing ten of the company's patents.

Later that year, Apple launched the Apple Watch Series 6, which has a blood oxygen test, and the dispute between the two companies escalated, and Masimo asked the International Trade Commission to ban the import of the watch. But the attempt failed, and the court ruled earlier this year that Apple had infringed only one of the patents. Apple is currently trying to overturn the ruling, and the final results will be announced next month. CTOnews.com noted that Apple also fought back, accusing Masimo of making Apple Watch clones.

In this patent war, the judge has dismissed five infringement charges filed by Masimo, and the remaining five have been handed over to the jury. Six of the seven jurors believed that Apple did not infringe any patents, but one juror held the opposite view, according to Bloomberg. The jury finally decided that a unanimous verdict could not be reached and reported the situation to the judge. U.S. District Judge James Selna annulled the case on Monday afternoon.

Masimo said he was disappointed with the result and intended to apply for a retrial. Apple, on the other hand, said it was satisfied with some of the victories, said it respected intellectual property rights and innovation, and would not steal or use confidential information from other companies. Apple also said it would ask the court to dismiss the remaining charges.

Masimo revealed that Apple had planned to buy the company, but was rejected by Apple CEO Tim Cook. Apple, on the other hand, sent "many employees involved in the sensor project" to testify that they did not use Masimo technology when developing Apple Watch's blood oxygen sensor.

Welcome to subscribe "Shulou Technology Information " to get latest news, interesting things and hot topics in the IT industry, and controls the hottest and latest Internet news, technology news and IT industry trends.